FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to an oral pharmaceutical composition which contains a suspension 0.5-50 wt % of total weight of the composition of a platinum complex (OC-6-43) bis(acetate)-(1-adamantylamino)amine-dichloroplatin (IV) (LA-12) of particle size 100 mcm and less in a pharmaceutically acceptable vegetable, animal, mineral, synthetic or semisynthetic oil and/or oily substance, and a pharmaceutically acceptable excipient. The composition under the invention can be used as a drug for cancer treatment.
EFFECT: invention provides the stable composition high in a complex of tetravalent platinum.
10 cl, 3 ex
